Femasys Inc
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornua… Read more
Femasys Inc (FEMY) - Total Assets
Latest total assets as of September 2025: $16.29 Million USD
Based on the latest financial reports, Femasys Inc (FEMY) holds total assets worth $16.29 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Femasys Inc - Total Assets Trend (2019–2024)
This chart illustrates how Femasys Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Femasys Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Femasys Inc's total assets of $16.29 Million consist of 64.5% current assets and 35.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 27.7% |
| Accounts Receivable | $488.37K | 3.9% |
| Inventory | $3.05 Million | 24.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $65.92K | 0.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Femasys Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Femasys Inc's current assets represent 64.5% of total assets in 2024, an increase from 63.6% in 2019.
- Cash Position: Cash and equivalents constituted 27.7% of total assets in 2024, down from 50.7% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 24.5% of total assets.
Femasys Inc Competitors by Total Assets
Key competitors of Femasys Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
OJsys Inc
PINK:OJSY
|
USA | $8.03 Million |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
Femasys Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Femasys Inc generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Femasys Inc is currently not profitable relative to its asset base.
Femasys Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 3.94 | 1.34 |
| Quick Ratio | 0.61 | 3.26 | 1.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.71 Million | $ 8.43 Million | $ 974.60K |
Femasys Inc - Advanced Valuation Insights
This section examines the relationship between Femasys Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.79 |
| Latest Market Cap to Assets Ratio | 2.35 |
| Asset Growth Rate (YoY) | -55.2% |
| Total Assets | $12.45 Million |
| Market Capitalization | $29.30 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Femasys Inc's assets at a significant premium ( 2.35x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Femasys Inc's assets decreased by 55.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Femasys Inc (2019–2024)
The table below shows the annual total assets of Femasys Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $12.45 Million | -55.16% |
| 2023-12-31 | $27.76 Million | +64.28% |
| 2022-12-31 | $16.90 Million | -40.88% |
| 2021-12-31 | $28.58 Million | +275.70% |
| 2020-12-31 | $7.61 Million | -39.85% |
| 2019-12-31 | $12.65 Million | -- |